Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

212

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

212 results for “nicotinamide”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov32/100

Nicotinamide Supplementation Improves Physical Performance in Older Adults at Risk of Falls

ClinicalTrials.gov study NCT06465602. IPD Sharing: NO. Countries: 1. Publications: 19.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

NR-SAFE: Safety of High-dose Nicotinamide Riboside (NR) in Parkinson's Disease

ClinicalTrials.gov study NCT05344404. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Nicotinamide in the Treatment of Psoriasis

ClinicalTrials.gov study NCT01763424. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Efficacy and Safety of 30% Salicylic Acid and 10% Nicotinamide Combined Therapy in Melasma

ClinicalTrials.gov study NCT07062120. IPD Sharing: NO. Countries: 1. Publications: 7.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Anticancer Activity of Nicotinamide on Lung Cancer

ClinicalTrials.gov study NCT02416739. IPD Sharing: NO. Countries: 1. Publications: 18.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Nicotinamide Riboside Impact on Extracellular Nicotinamide Adenine Dinucleotide (NAD+)

ClinicalTrials.gov study NCT06005350. IPD Sharing: NO. Countries: 1. Publications: 8.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Improved Skin Whitening Outcomes Associated With Nicotinamide Fortified Consumption in 30 to 50- Year-old Women

ClinicalTrials.gov study NCT05696938. IPD Sharing: NO. Countries: 1. Publications: 5.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)

ClinicalTrials.gov study NCT03707652. IPD Sharing: NO. Countries: 1. Publications: 13.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

ClinicalTrials.gov study NCT03821623. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients

ClinicalTrials.gov study NCT06078605. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

LncRNA Nicotinamide Nucleotide Transhydrogenase-Antisense RNA1 NNT-AS1 in CRC

ClinicalTrials.gov study NCT06531902. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate

ClinicalTrials.gov study NCT06044935. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans

ClinicalTrials.gov study NCT03754842. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition

ClinicalTrials.gov study NCT02942888. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Comparison of Nicotinamide Treatments for Actinic Keratosis

ClinicalTrials.gov study NCT07049068. IPD Sharing: YES. Countries: 1. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Nicotinamide Riboside and Metabolic Health

ClinicalTrials.gov study NCT02835664. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

ClinicalTrials.gov study NCT04844528. IPD Sharing: NO. Countries: 1. Publications: 15.

closedIPD-NOFeb 2026View details →
dryad32/100

Nicotinamide riboside and pterostilbene cooperatively delay motor neuron failure in ALS SOD1G93A mice

Open the record for dataset details and reuse information.

publicNov 2020View details →
zenodo28/100

Dataset related to article "Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells"

<p>Cancer induces alteration of hematopoiesis to fuel disease progression. We report that in tumor-bearing mice the macrophage colony-stimulating factor elevates the myeloid cell levels of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in the NAD salvage pathway, which acts as negative regulator of the CXCR4 retention axis of hematopoietic cells in the bone marrow. NAMPT inhibits CXCR4 through a NAD/Sirtuin 1-mediated inactivation of HIF1&alpha;-driven <em>CXCR4</em> gene transcription, leading to mobilization of immature myeloid-derived suppressor cells (MDSC) and enhancing their production of suppressive nitric oxide. Pharmacologic inhibition or myeloid-specific ablation of NAMPT prevented MDSC mobilization, reactivated specific antitumor immunity, and enhanced the antitumor activity of immune checkpoint inhibitors. Our findings identify NAMPT as a metabolic gate of MDSC precursor function, providing new opportunities to reverse tumor immunosuppression and to restore clinical efficacy of immunotherapy in patients with cancer. SIGNIFICANCE: These findings identify NAMPT as a metabolic gate of MDSC precursor function, providing new opportunities to reverse tumor immunosuppression and to restore clinical efficacy of immunotherapy in cancer patients.</p>

opencc-by-4.0Mar 2020View details →
ClinicalTrials.gov28/100

Nicotinamide Riboside and Mitochondrial Metabolism

ClinicalTrials.gov study NCT03951285. IPD Sharing: UNDECIDED. Countries: 0. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record